Osteoporosis, thin weak bones, is common in post-menopausal women and older men. While not fatal, it is a major risk for fractures and can severely impact your quality of life.

For example, activated T helper type 1 lymphocytes secrete interferon (IFN)-γ, which has potent effects on osteoclastogenesis in vivo and in vitro. IFN-γ, however, is known to cause both bone ...

(Annals of Surgery) HbA1c among young people with type 1 diabetes was 2.5 percentage ... the prevalence of osteoporosis among ...

A research team co-led by scientists at the University of Arizona College of Medicine—Tucson found that an osteoporosis drug might counter a rare genetic mutation underlying a type of heart disease.

Dublin, March 05, 2025 (GLOBE NEWSWIRE) -- The "Osteoporosis_Global Clinical Trials ... end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based ...

Women with osteoporosis have at least a 50% chance of reaching their target bone mineral density at 3 years if they have a BMD T-score of at least –2.8 at the total hip or –3.1 at the lumbar ...

which may increase the risk of developing osteoporosis (1 Trusted Source The Effect of Anti-Activin Receptor Type IIA and Type IIB Antibody on Muscle, Bone and Blood in Healthy and ...